| Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms TR De Kievit, MD Parkins, RJ Gillis, R Srikumar, H Ceri, K Poole, ... Antimicrobial agents and chemotherapy 45 (6), 1761-1770, 2001 | 409 | 2001 |
| A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients CD Sibley, MD Parkins, HR Rabin, K Duan, JC Norgaard, MG Surette Proceedings of the National Academy of Sciences 105 (39), 15070-15075, 2008 | 374 | 2008 |
| Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation MD Parkins, H Ceri, DG Storey Molecular microbiology 40 (5), 1215-1226, 2001 | 350 | 2001 |
| Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections CD Sibley, K Duan, C Fischer, MD Parkins, DG Storey, HR Rabin, ... PLoS pathogens 4 (10), e1000184, 2008 | 311 | 2008 |
| Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections MD Parkins, DM Sabuda, S Elsayed, KB Laupland Journal of antimicrobial chemotherapy 60 (3), 613-618, 2007 | 291 | 2007 |
| Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis MD Parkins, R Somayaji, VJ Waters Clinical microbiology reviews 31 (4), 10.1128/cmr. 00019-18, 2018 | 270 | 2018 |
| Culture enriched molecular profiling of the cystic fibrosis airway microbiome CD Sibley, ME Grinwis, TR Field, CS Eshaghurshan, MM Faria, SE Dowd, ... PloS one 6 (7), e22702, 2011 | 230 | 2011 |
| Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis MD Parkins, RA Floto Journal of Cystic Fibrosis 14 (3), 293-304, 2015 | 228 | 2015 |
| Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient ML Workentine, CD Sibley, B Glezerson, S Purighalla, JC Norgaard-Gron, ... PloS one 8 (4), e60225, 2013 | 227 | 2013 |
| Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study EO Billington, SH Phang, DB Gregson, JDD Pitout, T Ross, DL Church, ... International Journal of Infectious Diseases 26, 76-82, 2014 | 208 | 2014 |
| Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐Resistant Pseudomonas aeruginosa in the Calgary Health Region: Importance of … KB Laupland, MD Parkins, DL Church, DB Gregson, TJ Louie, JM Conly, ... Journal of Infectious Diseases 192 (9), 1606-1612, 2005 | 161 | 2005 |
| Population-Based Study of the Epidemiology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection MD Parkins, DB Gregson, JDD Pitout, T Ross, KB Laupland Infection 38, 25-32, 2010 | 141 | 2010 |
| The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature review MD Parkins, CD Sibley, MG Surette, HR Rabin Pediatric pulmonology 43 (5), 490-497, 2008 | 128 | 2008 |
| Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa MD Parkins, JC Rendall, JS Elborn Chest 141 (2), 485-493, 2012 | 115 | 2012 |
| Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics LJ Strug, T Gonska, G He, K Keenan, W Ip, PY Boelle, F Lin, N Panjwani, ... Human molecular genetics 25 (20), 4590-4600, 2016 | 112 | 2016 |
| Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review R Somayaji, MD Parkins, A Shah, SL Martiniano, MM Tunney, JS Kahle, ... Journal of Cystic Fibrosis 18 (2), 236-243, 2019 | 108 | 2019 |
| Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections JT Ngo, MD Parkins, DB Gregson, JDD Pitout, T Ross, DL Church, ... Infection 41, 41-48, 2013 | 90 | 2013 |
| The genus Prevotella in cystic fibrosis airways TR Field, CD Sibley, MD Parkins, HR Rabin, MG Surette Anaerobe 16 (4), 337-344, 2010 | 89 | 2010 |
| Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis N Acosta, A Heirali, R Somayaji, MG Surette, ML Workentine, CD Sibley, ... Thorax 73 (11), 1016-1025, 2018 | 87 | 2018 |
| Prevalence and outcomes of Achromobacter species infections in adults with cystic fibrosis: a North American cohort study BD Edwards, J Greysson-Wong, R Somayaji, B Waddell, FJ Whelan, ... Journal of clinical microbiology 55 (7), 2074-2085, 2017 | 84 | 2017 |
